but in the presence of heart failure the NT-proBNP is approximately four times higher than the corresponding BNP level, thus reducing the likelihood of a result in the ambiguous range; for example ...

Heart failure (HF) is a leading cause of morbidity and mortality worldwide. Testing for natriuretic peptide markers, such as B-type natriuretic peptide (BNP) or N-terminal proBNP (NT-proBNP), has ...

Creative Diagnostics announced the launch of its new range of BNP and NT-proBNP antibodies for raw material and research applications. NEW ...

but in the presence of heart failure the NT-proBNP is approximately four times higher than the corresponding BNP level, thus reducing the likelihood of a result in the ambiguous range (i.e. BNP ...

A natriuretic-peptide-guided approach to the management of HF was first tested in a pilot study of 69 patients in Christchurch, New Zealand by Troughton and colleagues. [41] In this study ...